MedPath

Effects of Fermented Kochi Golden Ginger Powder and Kochi Red Ginger Powder on Skin Surface Temperature

Not Applicable
Conditions
/A (healthy adults)
Registration Number
JPRN-UMIN000040490
Lead Sponsor
Oneness support Co., Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1)Those who have a history of diabetes, liver disease, kidney disease, digestive system disease, heart disease, or other diseases that may affect the results of this test, or who have had a history of surgery 2)Those with abnormal liver and renal function test values 3)Those who have a disease currently being treated 4)Those with food and drug allergies 5)Those who play intense sports and who are on a diet 6)Those who routinely use internal medicines (including foods and supplements) and skin medicines (applications, patches, sprays, etc.) that are expected to have health-promoting effects on skin tissues and blood / vascular functions 7)Those who cannot stop taking health foods (including foods for specified health use and foods with functional claims) and designated quasi-drugs during the test period 8)Those who continuously take medicines (including OTC and prescription medicines) 9)Those who routinely perform various therapies (esthetic treatment, massage, etc.) that are expected to have health-promoting effects on skin tissue and blood / vascular functions 10)Those with a marked abnormality in the skin condition at the test site or those with chronic skin symptoms such as atopic dermatitis 11)Heavy drinkers, or those who can't stop drinking from the day before the test until the day 12)Those with irregular life patterns and with lifestyle of reversal of day and night 13)Those who have habits of excessive eating and drinking 14)Those who have been pregnant or those who have a plan to become pregnant or breast feed during the study period 15)Those who are participating in or will be participating in other clinical trials at the start of this study, and those within 4 weeks after the end 16)Those who judged that examination responsible doctor is not appropriate for this study participation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath